Skip to content
Home/Companies/Biotech/BioClec

BioClec

Biotech·Italy·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns BioClec?

BioClec is an Italian Biotech company, currently owned by Sofinnova Partners since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Biovelocita I · 2022 · Life Sciences VC

Key facts

HQItaly
SectorBiotech

More from Sofinnova Biovelocita I

Other portfolio companies in the same fund.

Forth Therapeutics
Forth Therapeutics
Active
BiotechItaly· 2023

More Sofinnova Partners portfolio companies

From the same investor, across funds.

GenSight Biologics
GenSight Biologics
Active
BiotechFrance
CellCentric
CellCentric
Active
BiotechUnited Kingdom· 2026
Ingenix
Active
AI/MLPoland· 2026
P2 Science
P2 Science
Active
IndustrialsUnited States· 2026
Actithera
Actithera
Active
BiotechFrance· 2025
Bionyra Pharma
Active
BiotechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BioClec?

BioClec is currently owned by Sofinnova Partners, through Sofinnova Biovelocita I, since 2023.

When did Sofinnova Partners acquire BioClec?

Sofinnova Partners acquired BioClec in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue